Resting-state functional connectivity in multiple sclerosis patients receiving nabiximols for spasticity

BACKGROUND: Nabiximols (Sativex®) is a cannabinoid approved for multiple sclerosis (MS)-related spasticity. Its mechanism of action is partially understood, and efficacy is variable. OBJECTIVE: To conduct an exploratory analysis of brain networks connectivity changes on resting state (RS) functional...

Descripción completa

Detalles Bibliográficos
Autores principales: Gajofatto, Alberto, Cardobi, Nicolò, Gobbin, Francesca, Calabrese, Massimiliano, Turatti, Marco, Benedetti, Maria Donata
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10052832/
https://www.ncbi.nlm.nih.gov/pubmed/36991352
http://dx.doi.org/10.1186/s12883-023-03171-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10052832/
https://www.ncbi.nlm.nih.gov/pubmed/36991352
http://dx.doi.org/10.1186/s12883-023-03171-0

Ejemplares similares